Statins as candidate therapeutic agents for coronavirus disease 2019 (COVID-19).

Li, Sheng-De; Zhang, Shu-Yang; Peng, Bin

Li, Sheng-De; Zhang, Shu-Yang; Peng, Bin.

Li SD; Department of Neurology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100730, China.
Zhang SY; Department of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100730, China.
Peng B; Department of Neurology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100730, China.

Chin Med J (Engl) ; 134(4): 407-409, 2020 11 02.

Article in English | MEDLINE | ID: covidwho-1093608

Subject(s)

Antiviral Agents/therapeutic use; COVID-19 Drug Treatment; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use; COVID-19/virology; Humans; SARS-CoV-2/drug effects; SARS-CoV-2/pathogenicity

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Hydroxymethylglutaryl-CoA Reductase Inhibitors / COVID-19 Drug Treatment Limits: Humans Language: English Journal: Chin Med J (Engl) Year: 2020 Document Type: Article Affiliation country: Cm9.0000000000001205

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google